国家重点研发计划 1项 （核心骨干）

省自然面上 1 项 （主持）

1. Fang HT, El Farran CA, Xing QR, Li P, Cheng H, Tushar W, Xu J, Zhang LF, Li H, Lim B, Loh YH. (2018) Global H3.3 dynamics defines its bimodal role in cell fate transition. Nature Communications. Apr 18;9:1537

2. Mzoughi S, Zhang JX, Hequet D, Teo SX, FangHT, Xing QR, Bezzi M, Ong SL, Shin ME, Wollmann H, Wong E, Al-Haddawi M, Stewart C, Tergaonkar V, Dunn NR, Loh YH, Messerschmidt DM and Guccione E.(2017) PRDM15 safeguards naïve pluripotency by transcriptionally regulating WNT and MAPK/ERK signaling. Nature Genetics. Sep;49(9):1354-1363.

3. Cheng H, Ang YK, El Farran CA, Li P, Fang HT, Liu Tongming, Kong SL, Chin LZ, Ling WY, Lim KH, Li H, Huber T , Loh M, Loh YH, Lim B.(2016) Reprogramming Mouse Fibroblasts into EngraftableMyeloerythroid and Lymphoid Progenitors: Induction and Underlying Mechanisms. Nature Communications. Nov 21;7:13396.

4. Yang BX*, El Farran CA*, Guo HC*, Yu T*, Fang HT, Wang HF, Schlesinger S, Seah YF, Goh GY, Neo SP, Li Y, Lorincz MC, Tergaonkar V, Lim TM, Chen L, Gunaratne J, Collins JJ, Goff SP, Daley GQ, Li H, Bard FA, Loh YH. (2015) Systematic identification of factors for provirus silencing in embryonic stem cells. Cell. Sep; 163(1): 230-245.

5. Fang HT, Zhang B (Co-author), Pan XF, Gao L, Zhen T, Zhao HX, Ma L, Xie J, Liu Z, Yu XJ, Cheng X, Feng TT, Zhang FX, Yang Y, Hu ZG, Sheng GQ, Chen YL, Chen SJ, Chen Z, Zhou GB.(2012) Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor- suppressing fragments in leukemia cells. PNAS. Feb; 109(7): 2521-2526.

6. Zhou GS, Hu Z, Fang HT, Zhang FX, Pan XF, Chen XQ, Hu AM, Xu L, Zhou GB. (2011) Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells. Leukemia Research. Feb; 35(2): 214-218.